GeoVax Labs, Inc.
Pharmaceutical company · Smyrna, Georgia, United States · Nasdaq: GOVX
GeoVax Labs, Inc. is a pharmaceutical company headquartered in Smyrna, Georgia, United States. Its shares trade on Nasdaq under the ticker GOVX. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2022.
GeoVax Labs at a glance
What does GeoVax Labs do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $15 million sold (2022).
Frequently asked questions about GeoVax Labs
Where is GeoVax Labs headquartered?
GeoVax Labs, Inc. is headquartered in Smyrna, Georgia, United States.
What does GeoVax Labs do?
GeoVax Labs, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is GeoVax Labs a public company?
Yes. GeoVax Labs, Inc. trades on Nasdaq under the ticker GOVX.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences